Portfolio
Biotechnology company focused on accelerating breakthroughs in protein conjugate therapeutic development for cancer and other life-threatening diseases
Clinical-stage biotech discovering and developing allogeneic gamma delta T cell therapies
Late clinical-stage Biopharmaceutical company discovering and developing therapies for the treatment of renal diseases and related chronic conditions
Clinical-stage biotechnology company focused on developing the next generation of oncology therapies for patients
Late clinical -stage biotech with one of the largest pipelines of novel, non-opioid therapies for chronic pain management
UK clinical-stage biotech developing potent, multi-functional Humabody therapeutics
Clinical stage biotechnology company developing breakthrough therapies based on GeneTAC™ platform to address diseases caused by genetic expansion
Clinical-stage biotechnology company focusing on innovative therapeutics in ophthalmic diseases
Biotech company specializing in non-absorbable drugs for metabolic diseases
Clinical-stage biotech discovering breakthrough therapies for complement-mediated diseases
Precision medicine leader in China offering integrated solutions of biomarkers, companion diagnostics and clinical testing
Clinical-stage biotech discovering and developing first-in-class immunotherapy-based biologics for cancer and other diseases
Biotechnology company focused on developing first-in-class oral peptide pipeline against validated biologic targets with large unmet needs
Late clinical-stage biotech with an integrated platform for the development and commercialization of rare disease medicines in China
Harnesses the power of first-in-category programmable payloads of eRNA, nanoparticles, and emerging, proprietary AI technologies, to unlock the comprehensive programming of medicines
Emerging AI-empowered technology company in China, leveraging unique algorithms to facilitate data-driven life science research
Leading Chinese biotech focusing on next-generation RNA technology with global potential in multiple disease areas
Clinical-stage, drug development company committed to improving outcomes for people living with advanced immunological diseases with an initial focus on severe respiratory conditions
Late clinical-stage immuno-oncology biotech with novel, proprietary pipeline
Leading Chinese specialty clinical development CRO that serves local and global biotech/pharma clients
Preclinical stage biotech company developing a paradigm-shifting platform for cell-specific in vivo gene delivery
